Stenocare AS (STENO) - Cash Flow Conversion Efficiency

Latest as of June 2026: 0.180x

Based on the latest financial reports, Stenocare AS (STENO) has a cash flow conversion efficiency ratio of 0.180x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Dkr1.54 Million ≈ $241.72K USD) by net assets (Dkr8.59 Million ≈ $1.34 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see STENO stock market capitalisation for the company's overall valuation and market capitalisation.

Stenocare AS - Cash Flow Conversion Efficiency Trend (2018–2025)

This chart illustrates how Stenocare AS's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Stenocare AS Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Stenocare AS ranked by their cash flow conversion efficiency. Explore Stenocare AS (STENO) cash flow quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Arbor Metals Corp V:ABR	-0.006x
FIREFOX GOLD CORP. F:FIY	N/A
Bank Danamon Indonesia Tbk JK:BDMN	0.048x
Auddia Inc NASDAQ:AUUD	-0.235x
Witbe Net SA PA:ALWIT	0.366x
Nextage Therapeutics Ltd TA:NXTG	0.311x
Biofil Chemicals & Pharmaceuticals Limited NSE:BIOFILCHEM	-0.167x
Singularity Future Technology Ltd NASDAQ:SGLY	-0.798x

Annual Cash Flow Conversion Efficiency for Stenocare AS (2018–2025)

The table below shows the annual cash flow conversion efficiency of Stenocare AS from 2018 to 2025. View today's stock price for Stenocare AS for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Dkr9.47 Million ≈ $1.48 Million	Dkr-7.21 Million ≈ $-1.13 Million	-0.762x	-137.05%
2024-12-31	Dkr-3.47 Million ≈ $-543.48K	Dkr-7.14 Million ≈ $-1.12 Million	2.056x	+628.68%
2023-12-31	Dkr25.82 Million ≈ $4.04 Million	Dkr-10.04 Million ≈ $-1.57 Million	-0.389x	+37.55%
2022-12-31	Dkr24.14 Million ≈ $3.78 Million	Dkr-15.03 Million ≈ $-2.35 Million	-0.623x	-87.79%
2021-12-31	Dkr40.24 Million ≈ $6.30 Million	Dkr-13.34 Million ≈ $-2.09 Million	-0.332x	-37.22%
2020-12-31	Dkr52.57 Million ≈ $8.23 Million	Dkr-12.70 Million ≈ $-1.99 Million	-0.242x	-27.96%
2019-12-31	Dkr13.47 Million ≈ $2.11 Million	Dkr-2.54 Million ≈ $-398.12K	-0.189x	+30.65%
2018-12-31	Dkr20.47 Million ≈ $3.20 Million	Dkr-5.57 Million ≈ $-872.16K	-0.272x	--

About Stenocare AS

CO:STENO Denmark Drug Manufacturers - Specialty & Generic

Market Cap

$5.80 Million

Dkr37.06 Million DKK

Market Cap Rank

#28408 Global

#136 in Denmark

Share Price

Dkr0.86

Change (1 day)

-3.38%

52-Week Range

Dkr0.80 - Dkr2.72

All Time High

Dkr37.18